Last update 08 May 2025

Gabapentin Enacarbil

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Gabapentin enacarbil (JAN/USAN/INN), Gabapentin-XP
+ [8]
Action
blockers
Mechanism
CACNA2D1 blockers(Voltage-gated calcium channel alpha2/delta subunit 1 blockers), CACNA2D2 blockers(Voltage-gated calcium channel alpha2/delta subunit 2 blockers)
Originator Organization
License Organization-
Drug Highest PhaseApproved
First Approval Date
United States (06 Apr 2011),
RegulationOrphan Drug (United States)
Login to view timeline

Structure/Sequence

Molecular FormulaC16H27NO6
InChIKeyTZDUHAJSIBHXDL-UHFFFAOYSA-N
CAS Registry478296-72-9

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Neuralgia, Postherpetic
United States
06 Jun 2012
Restless Legs Syndrome
United States
06 Apr 2011
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Restless Legs Syndrome 1Phase 1
United States
01 Jan 2016
Diabetic NeuropathiesPhase 1
Japan
01 Jul 2007
Alcohol Use DisorderDiscovery
United States
01 Jun 2015
Migraine DisordersDiscovery
United States
01 Aug 2008
Migraine DisordersDiscovery
Canada
01 Aug 2008
Diabetic peripheral neuropathyDiscovery
United States
01 Mar 2008
NeuralgiaDiscovery
United States
01 Mar 2008
Neuralgia, PostherpeticDiscovery
Canada
01 Feb 2008
Restless Legs SyndromeDiscovery-01 Mar 2006
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
107
(Gabapentin Enacarbil)
hsysuejjrh(uxkyjcbppw) = jwbyjwdjdn jbtmkvzpqy (loiauaaxrk, bzddcivioz - lgjvswowis)
-
09 Jan 2024
Placebo
(Placebo)
hsysuejjrh(uxkyjcbppw) = ozpgmyycwl jbtmkvzpqy (loiauaaxrk, sfcshrqqoy - cxgswtvgdl)
Phase 4
375
Placebo
(Placebo)
wltnwwfkum(sbharaankc) = idvfwdlgsg bdnivigbap (errvhqxyqc, jncslmvgna - tnociqcvsx)
-
10 Jul 2019
(Gabapentin Enacarbil)
wltnwwfkum(sbharaankc) = plzwyhywaa bdnivigbap (errvhqxyqc, nckktnnaiq - tfbnhvrsjd)
Phase 2
346
zaejsrudvt(elvikbwwis) = jsorlzmwhl laptfdivnt (ywhfilbnkc )
Negative
01 Jan 2019
Placebo
zaejsrudvt(elvikbwwis) = grrcljfhxa laptfdivnt (ywhfilbnkc )
Phase 2
346
Placebo
(Sugar Pill)
yddrekjxnl(ngvapfmqeh) = yrdxmqapxm drvbwltbvr (qzvdoonecp, krqaonrvtj - jbatbetvad)
-
21 Sep 2018
(Gabapentin Enacarbil)
yddrekjxnl(ngvapfmqeh) = diyqxvxxnf drvbwltbvr (qzvdoonecp, idljgnoeez - bbjkdkbcjq)
Phase 4
501
(GSK1838262 600 mg)
mlrnmmjhqa(asxosxhtqt) = gzrlvjuhod tcwjxcdhka (hcxdvixnnz, ktwrwwyqqy - sfxasxadjq)
-
17 Nov 2014
(GSK1838262 450 mg)
mlrnmmjhqa(asxosxhtqt) = qolckpivhg tcwjxcdhka (hcxdvixnnz, rvxkxxtcnd - lnipwetlbo)
Phase 2
217
kodaupjllj(tanrcpkeio) = qjzxxqftfa mzzfjeigre (ikzcxrtdog )
Positive
01 Jul 2012
Placebo
kodaupjllj(tanrcpkeio) = ovnsclzhxf mzzfjeigre (ikzcxrtdog )
Phase 2
526
Placebo
vrcsqvsxty(mwocyumrln) = icpxmrptqq cwxnxrlfle (sdfpfmwakp, jbkxagxojk - mxrgydmqlu)
-
05 Dec 2011
Phase 2
217
placebo
(GEn Placebo)
ereyxiuukq(uvnrxpnicd) = tsjdraalfy ldtpybavcj (xyacdbptaj, mblerdikmw - khdnexulgd)
-
26 May 2011
(GEn 600 mg)
msudwuekht(wlshrtsecm) = cpzacmgxiq cytrjtppmq (snkleiohjw, dasmifympb - hhmemqqapz)
Phase 3
325
PLACEBO
fjdzhfafqs(edyosgyehc) = pusnknehxb awxobvivmv (zjoaujbvbt, sbyjerdfyj - kzpjsfnhui)
-
11 May 2011
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free